ArticleToxicological research2025

Targeting IDH1 mutation-driven Nrf2 signaling to suppress malignant behavior in fibrosarcoma cells.

Seoyeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.